伏环孢素可改善狼疮性肾炎的预后。 - Suppr

Suppr

超能文献

Voclosporin improves outcomes in lupus nephritis.

作者信息

Clarke Joanna

机构信息

Nature Reviews Rheumatology, .

出版信息

Nat Rev Rheumatol. 2021 Jul;17(7):378. doi: 10.1038/s41584-021-00638-7.

DOI:10.1038/s41584-021-00638-7

PMID:34040229

Abstract

摘要

相似文献

Voclosporin improves outcomes in lupus nephritis.

Nat Rev Rheumatol. 2021 Jul;17(7):378. doi: 10.1038/s41584-021-00638-7.

Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.

Expert Rev Clin Pharmacol. 2022 May;15(5):515-529. doi: 10.1080/17512433.2022.2092470. Epub 2022 Jul 11.

Voclosporin (Lupkynis) for lupus nephritis.

Med Lett Drugs Ther. 2021 Aug 23;63(1631):134-136.

An evaluation of voclosporin for the treatment of lupus nephritis.

Expert Opin Pharmacother. 2018 Oct;19(14):1613-1621. doi: 10.1080/14656566.2018.1516751. Epub 2018 Sep 12.

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

Kidney Int. 2019 Jan;95(1):219-231. doi: 10.1016/j.kint.2018.08.025. Epub 2018 Nov 9.

Voclosporin: First Approval.

Drugs. 2021 Apr;81(5):605-610. doi: 10.1007/s40265-021-01488-z.

How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not.

Kidney Int. 2021 Dec;100(6):1185-1189. doi: 10.1016/j.kint.2021.06.036. Epub 2021 Jul 17.

Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis.

Cells. 2023 Oct 11;12(20):2440. doi: 10.3390/cells12202440.

Calcineurin inhibitors in lupus nephritis.

J Nephrol. 2021 Apr;34(2):399-402. doi: 10.1007/s40620-020-00757-6.

AURORA 1 reports efficacy of voclosporin in lupus nephritis.

Nat Rev Nephrol. 2021 Oct;17(10):637-638. doi: 10.1038/s41581-021-00460-0.

引用本文的文献

Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.

Mol Med. 2023 Jul 24;29(1):99. doi: 10.1186/s10020-023-00672-z.

Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis.

Front Med (Lausanne). 2023 Jun 9;10:1177450. doi: 10.3389/fmed.2023.1177450. eCollection 2023.

Loss of Gut Barrier Integrity In Lupus.

Front Immunol. 2022 Jun 20;13:919792. doi: 10.3389/fimmu.2022.919792. eCollection 2022.

本文引用的文献

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet. 2021 May 29;397(10289):2070-2080. doi: 10.1016/S0140-6736(21)00578-X. Epub 2021 May 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验